Results 201 to 210 of about 266,382 (322)
Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy.
A. Wilde, A. Amin
semanticscholar +1 more source
Abstract Sudden deaths in infants and children represent a profound and tragic event that continues to challenge researchers despite extensive investigation over several decades. The predominant phenotype, sudden infant death syndrome (SIDS), has evolved into the broader category of sudden unexpected infant death (SUID).
Suvasini Sharma+3 more
wiley +1 more source
Apparent Ventricular Bigeminy in the Congenital Long QT Syndrome: What is the Mechanism? [PDF]
Yen‐Bin Liu+2 more
openalex +1 more source
Abstract Background Opioid use disorder (OUD) is an emerging and global public health concern, and its management remains inadequate, notably due to a lack of biomarkers, except for the CYP2B6 genetic polymorphisms. Objectives Hence, the aim of this study was to assess the influence of genetic polymorphisms of ABCB1, SLC22A1, COMT, and OPRM1 on ...
Abd El Kader Ait Tayeb+8 more
wiley +1 more source
Acquired Genotype-Positive Long QT Syndrome After Pediatric Heart Transplantation. [PDF]
Barresi NV+3 more
europepmc +1 more source
Long QT syndrome: Genetic implications and drug influence [PDF]
Gojković-Bukarica Ljiljana+1 more
core +1 more source
A trace amine beta‐phenylethylamine is anxiolytic and reduces brain acetylcholine at 12 μg/L, but elevates anxiety and cortisol levels at 1000 μg/L. Acute tryptamine at 7 mg/L is anxiogenic, reduces shoaling and social interaction, but elevates brain acetylcholine and cortisol levels. Acute tyramine at 15 μg/L, and octopamine at 125, 500, and 1500 μg/L,
Thalia M. Quintanilha+10 more
wiley +1 more source